Empagliflozin, Sitagliptin, and Metformin: Uses, Benefits, and Side Effects

Oct 21, 2026

Gliempaflozin 3D 25 is used, along with diet and exercise, to improve blood sugar control in adults with type 2 diabetes mellitus whose diabetes is not adequately controlled on one or two of these medicines, or who already take the three ingredients separately at these doses and prefer a single tablet. It is not a starter medicine for most people newly diagnosed with diabetes.

Here is what each ingredient is commonly used for:

Empagliflozin tablet uses: lowering blood sugar in type 2 diabetes. Empagliflozin is also used, as a standalone medicine, to reduce the risk of cardiovascular death in adults with type 2 diabetes and established heart disease, and in heart failure and chronic kidney disease. These extra benefits are established for empagliflozin on its own, and a combination tablet is chosen mainly for blood sugar control.
Sitagliptin tablet uses: lowering blood sugar in type 2 diabetes by boosting the body’s own incretin hormones. Sitagliptin 100 mg is the standard full dose in adults with normal kidney function.
Metformin hydrochloride tablets uses: the most widely used first-line diabetes medicine. It lowers glucose production by the liver and improves how the body responds to insulin.

Gliempaflozin 3D 25 is not used for type 1 diabetes or for diabetic ketoacidosis. It supports your diabetes plan and does not replace healthy eating, activity, weight management, and regular monitoring.

Why Is Combination Therapy With Empagliflozin, Sitagliptin and Metformin Important?

Type 2 diabetes is progressive. Over the years, the pancreas often produces less insulin and the body responds to it less well, so one medicine may stop being enough. Uncontrolled blood sugar damages the eyes, kidneys, nerves, heart, and blood vessels over time.

Combination therapy matters for several reasons:

Different drugs attack different problems. One reduces glucose output from the liver, one helps the pancreas respond to meals, and one makes the kidneys remove sugar in the urine.
Lower doses of each can be effective. Combining mechanisms can give a larger effect than raising one drug alone.
Fewer tablets improve adherence. Many people with diabetes take several medicines, and a single tablet is easier to remember. Better adherence is linked to better control.
Early and effective control protects organs. Keeping HbA1c in the target range reduces the risk of complications.
Low hypoglycemia risk. None of the three medicines on its own commonly causes dangerously low blood sugar, which is a practical advantage over sulfonylureas and insulin.
Possible extra benefits. Empagliflozin has proven cardiovascular and kidney benefits, and metformin and empagliflozin can help with weight or are weight neutral.

Key Benefits

What Are the Benefits of Empagliflozin Sitagliptin Metformin?

1. Stronger HbA1c reduction. Adding agents with complementary actions typically lowers HbA1c more than any one of them alone.

2. Lowers both fasting and after-meal glucose. Metformin acts largely on fasting sugar, sitagliptin on after-meal sugar, and empagliflozin on glucose throughout the day.

3. Low risk of hypoglycemia. Used without insulin or sulfonylureas, the combination rarely causes low blood sugar.

4. May help with weight and blood pressure. Empagliflozin generally causes modest weight loss and small reductions in blood pressure. Metformin is typically weight neutral or mildly weight-reducing, and sitagliptin is weight neutral.

5. Cardiovascular and kidney protection from empagliflozin. In the EMPA-REG OUTCOME trial, empagliflozin reduced cardiovascular death and hospitalization for heart failure in adults with type 2 diabetes and established cardiovascular disease, and later trials showed kidney and heart failure benefits.

6. Neutral heart safety for sitagliptin. The TECOS trial showed that sitagliptin did not increase major cardiovascular events compared with placebo in type 2 diabetes.

7. One tablet, once a day. A simple schedule can help you stay consistent.

8. Convenient for people already on the three drugs. It replaces three separate tablets.

Mechanism of Action:

The mechanism of action of empagliflozin sitagliptin metformin combines three separate pathways.

Empagliflozin (SGLT2 inhibitor)

Blocks the sodium-glucose co-transporter 2 (SGLT2) in the kidney tubules, which normally reabsorb most filtered glucose back into the blood.
With SGLT2 blocked, the kidneys pass the extra glucose into the urine, so blood sugar falls independently of insulin.
This also removes some calories and fluid, which helps explain weight loss and small blood pressure reductions.

Sitagliptin (DPP-4 inhibitor)

Blocks the enzyme dipeptidyl peptidase-4 (DPP-4), which normally breaks down incretin hormones such as GLP-1 and GIP.
Higher incretin levels increase insulin release from the pancreas and reduce glucagon release from the liver only when blood sugar is high, which is why hypoglycemia is uncommon.

Metformin (biguanide)

Reduces glucose production by the liver.
Improves insulin sensitivity in muscle and other tissues, so cells take up glucose more effectively.
Slightly lowers glucose absorption from the gut. It works partly by activating AMPK, an energy-sensing enzyme in cells.

In simple terms, metformin tells the liver to release less sugar, sitagliptin helps the pancreas respond to meals, and empagliflozin lets the kidneys flush out excess sugar. Each addresses a different part of how type 2 diabetes raises blood glucose.

Indications, Efficacy and Clinical Evidence

Indications: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, in patients inadequately controlled on a dual combination of these agents, or already treated with the three medicines separately. Approved indications and populations differ by country, so follow the label for Gliempaflozin 3D 25.

What does the evidence say?

Sitagliptin plus metformin: Randomized trials showed that adding sitagliptin to metformin lowers HbA1c more than metformin plus placebo, with a low rate of hypoglycemia and no weight gain. Fixed-dose sitagliptin-metformin has long been a widely used combination.
Empagliflozin plus metformin: Trials showed that adding empagliflozin to metformin lowers HbA1c, body weight, and blood pressure compared with placebo. Doses of 10 mg and 25 mg both worked, with 25 mg often giving a slightly larger effect.
Triple therapy: Studies of adding empagliflozin to metformin plus a DPP-4 inhibitor, and of combined SGLT2 and DPP-4 therapy on a metformin background, show additive HbA1c reductions. The size of the additional benefit depends on baseline HbA1c, kidney function, and duration of diabetes.
Cardiovascular and kidney outcomes: EMPA-REG OUTCOME showed reduced cardiovascular death and heart failure hospitalization with empagliflozin. Later trials in heart failure and chronic kidney disease extended those benefits. TECOS showed that sitagliptin was cardiovascularly neutral.
Early combination therapy: The VERIFY study showed that starting a metformin plus DPP-4 inhibitor combination early helped people stay at their HbA1c target longer than starting with metformin alone and adding drugs later.

Dosage Guidelines

Always follow your doctor’s prescription and the leaflet in your pack. General guidance:

Adults: Usually one tablet once daily, taken with a meal, often breakfast. Because the tablet already contains the maximum daily dose of empagliflozin for blood sugar control (25 mg), do not take it twice a day unless your doctor specifically instructs it and the label allows it.
How to take: Swallow the tablet whole with water. If it is an extended-release formulation, do not crush, chew, or split it. Taking it with food reduces the stomach upset that metformin can cause.
Kidney function: Your doctor will check your eGFR before you start and regularly afterward. This fixed-dose tablet is generally not suitable if kidney function is reduced, because the sitagliptin dose must be lowered when eGFR falls below 45, and metformin should not be used when eGFR is below 30 and is generally not started between 30 and 45. Your doctor may switch you to separate tablets so each dose can be adjusted.
Elderly: Used with kidney function checks and careful monitoring.
Children and adolescents: Not recommended for this combination unless a specialist prescribes it.
Missed dose: Take it as soon as you remember on the same day with food. If it is nearly time for the next day’s dose, skip the missed one. Do not take two tablets in one day.
Overdose: An excessive dose can cause lactic acidosis (from metformin), with symptoms such as weakness, rapid breathing, stomach pain, and drowsiness. Seek emergency medical help immediately.
Sick days: If you have vomiting, diarrhoea, fever, or cannot eat or drink, tell your doctor. You may need to pause the tablet temporarily to reduce the risk of dehydration, kidney strain, and ketoacidosis.
Before surgery or contrast scans: Tell your doctor that you take it. Empagliflozin is usually stopped a few days before planned surgery, and metformin may need to be paused around iodinated contrast imaging. Follow your care team’s instructions.

Side Effects

Many people tolerate the combination well. Common side effects include:

Genital yeast infections (thrush) in both women and men, caused by sugar in the urine
Urinary tract infections
Increased urination and mild thirst
Nausea, diarrhoea, stomach discomfort, bloating, or gas (mostly from metformin, often improving over time)
Metallic taste in the mouth
Headache or runny nose and sore throat (upper respiratory tract symptoms with sitagliptin)
Mild dizziness from lower blood pressure or fluid loss
Low blood sugar if combined with insulin or a sulfonylurea

Good hygiene, drinking enough fluids, and prompt treatment of symptoms usually help. Tell your doctor if any side effect bothers you or does not settle.

Available Substitutes

If Gliempaflozin 3D 25 is unavailable, a pharmacist can suggest a product with the same three ingredients and strengths, since brands and availability differ by country. Do not swap to a different strength without medical advice, because empagliflozin, sitagliptin, and metformin each have their own dosing limits.

Other options your doctor may consider include:

Sitagliptin and metformin fixed-dose tablets (for example, brands such as Janumet and Zituvimet)
Empagliflozin and metformin fixed-dose tablets (for example, Synjardy)
Triple combinations with a different DPP-4 inhibitor (for example, empagliflozin, linagliptin, and metformin, sold in some markets as Trijardy XR)
Empagliflozin alone (for example, Jardiance), plus separate sitagliptin and metformin tablets, which lets each dose be adjusted independently
Other classes, such as GLP-1 receptor agonists, pioglitazone, sulfonylureas, or insulin, depending on your needs, kidney function, heart risk, and weight goals

Never change diabetes medicines on your own. Even a switch between similar-looking products can affect blood sugar control and safety.

Precautions and Warnings

Type 1 diabetes and ketoacidosis: Do not use if you have type 1 diabetes or a history of diabetic ketoacidosis. Know the warning signs.
Kidney disease: Needs eGFR checks before and during treatment. Avoid or switch to separate doses if kidney function is reduced, as described above.
Liver disease: Metformin should generally be avoided in significant liver impairment because of lactic acidosis risk.
Alcohol: Avoid heavy or binge drinking, which increases the risk of lactic acidosis and hypoglycemia.
Contrast dyes and surgery: Tell radiology and surgical teams you take this tablet. You may be asked to pause it.
Dehydration and low blood pressure: Take care in hot weather, during illness, if you take diuretics or blood pressure medicines, and if you are elderly. Drink fluids as advised.
Genital and urinary infections: Maintain good genital hygiene and report symptoms early.
History of pancreatitis, gallstones, or heavy alcohol use: Discuss this with your doctor before starting sitagliptin.
Heart failure: Tell your doctor. Empagliflozin is used in heart failure, but your doctor will review your whole treatment.
Hypoglycemia with other diabetes medicines: If you also take insulin or a sulfonylurea, your doctor may lower their doses. Learn the symptoms of low blood sugar (sweating, shaking, hunger, confusion) and carry fast-acting sugar.
Vitamin B12: Long-term metformin use can lower B12. Your doctor may check levels periodically.
Pregnancy: Not recommended, especially in the second and third trimesters. If you are planning a pregnancy or become pregnant, contact your doctor to switch to a safer plan.
Breastfeeding: Not recommended without medical advice.
Weight loss and low-calorie or ketogenic diets: Strict low-carbohydrate or very low-calorie diets can raise the risk of ketoacidosis. Discuss dietary changes with your doctor.
Foot and skin care: Check your feet daily, and report sores, blisters, or infections.
Driving and machinery: Dizziness can occur, especially when starting treatment or if you are dehydrated.
Monitoring: Keep regular appointments for HbA1c, kidney function, liver function, blood pressure, lipid levels, and eye and foot checks.
Allergy: Do not use if you are allergic to empagliflozin, sitagliptin, metformin, or any ingredient in the tablet.
Storage: Keep in a cool, dry place, away from moisture and direct sunlight, in the original blister pack, and out of the reach of children. Check the expiry date.

Frequently Asked Questions (FAQs)

1. What is empagliflozin sitagliptin metformin used for?
It is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes who need three medicines.

2. What is Gliempaflozin 3D 25?
It is a fixed-dose tablet by Steris Healthcare containing empagliflozin 25 mg, sitagliptin 100 mg, and metformin hydrochloride 1000 mg.

3. What are empagliflozin tablet uses?
Empagliflozin lowers blood sugar in type 2 diabetes and, as a standalone medicine, also lowers cardiovascular risk and is used in heart failure and chronic kidney disease.

4. What are sitagliptin tablet uses?
Sitagliptin lowers blood sugar in type 2 diabetes by increasing the body’s insulin response after meals and reducing glucagon.

5. What does sitagliptin 100 mg do?
It is the standard adult dose of sitagliptin and helps control blood sugar by blocking the DPP-4 enzyme.

6. What are metformin hydrochloride tablets used for?
Metformin is a first-line medicine for type 2 diabetes. It reduces glucose production by the liver and improves insulin sensitivity.

7. How do I take Gliempaflozin 3D 25?
Usually one tablet once a day with a meal, swallowed whole with water, as your doctor directs.

8. Can I take Gliempaflozin 3D 25 twice a day?
No, not unless your doctor specifically instructs it. The tablet already contains the maximum daily blood sugar dose of empagliflozin.

9. How long does it take to lower blood sugar?
Blood sugar usually improves within days, and HbA1c reflects the full effect after about three months.

10. What are the common side effects of empagliflozin sitagliptin metformin?
Genital yeast infections, urinary tract infections, increased urination, nausea, diarrhoea, and stomach upset are common.

Conclusion

Gliempaflozin 3D 25 by Steris Healthcare is a fixed-dose empagliflozin sitagliptin metformin tablet that helps adults with type 2 diabetes bring blood sugar down by three complementary routes: less glucose from the liver, better insulin response after meals, and more sugar passed out in the urine. Clinical trials support the benefit of each ingredient and of their combinations, and empagliflozin has proven heart and kidney benefits as a single drug. The tablet is taken once daily with a meal, but it needs care in people with kidney problems, a risk of dehydration, or a history of ketoacidosis or pancreatitis, and it must be paused during serious illness, certain scans, and surgery. Take it exactly as prescribed, keep up your diet and activity plan, attend regular check-ups, and contact your doctor promptly if you notice warning symptoms.

For Further Information:

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +91 8824175417, +91 9982524671

Buy Now

SHARE WITH